UChicago researchers have developed a new blood test that uses RNA modifications to detect early-stage colorectal cancer with ...

While the liquid biopsy technology continues to evolve for lung cancer management, researchers are working toward further ...

Liquid biopsy technologies are maturing at a rapid pace. They are already being used as a precision medicine tool, helping clinicians match a patient’s cancer to targeted therapies.

Liquid biopsy’s potential as a diagnostic in cancer is gaining recognition, and its advantages over tissue biopsy in non-small cell lung cancer (NSCLC) were featured in research recently ...

A research team has developed a technology that distinguishes lung cancer gene mutations solely by measuring the "stiffness" of exosomes—tiny particles released from cancer cells in the ...

NeoGenomics launched the NEO PanTracer™ LBx, a blood-based comprehensive genomic profiling test, expanding the company’s ...

Liquid biopsy is a new technique that makes it easier to identify and monitor lung cancer without surgery. In India, this ...

Liquid biopsy offers a screening option to diagnose early-stage cancers via a single blood test. To drive clinical adoption, multi-omic approaches will help improve test accuracy.

LONDON--(BUSINESS WIRE)--The global liquid biopsy market is expected to grow by USD 4.02 billion as per Technavio. This marks a significant market slow down compared to the 2019 growth estimates ...

Liquid Biopsy Market: Technology Landscape Based on technology, the market saw maximum growth in the CTC and ctDNA segment in 2019. ctDNA test is the most preferred procedure due to its highly ...

What a blood test for cancer can tell you Looking at more than 17,628 samples collected from 15,191 patients using a test from liquid biopsy company Guardant Health, researchers from Guardant and ...